List view / Grid view
Scientists have succeeded in printing 3D structures with living cells, this enables the production of micro building blocks that are viable and can be used for repairing damaged tissue...
Researchers have successfully applied a novel combination therapy to restore skin colour in patients with vitiligo...
Injecting minute amounts of two immune-stimulating agents directly into solid tumours in mice can eliminate all traces of cancer...
The NIH is teaming with the government, biopharmaceutical, life science and non-profit organisations to overcome obstacles and increase success for advancing promising treatments for PD...
Bursting oxygen-filled microbubbles in breast cancer makes tumours three times more sensitive to radiation therapy in preliminary tests with animal models of the disease...
A new study reveals the efficacy and safety of using intravenous bevacizumab to treat patients with severe hereditary haemorrhagic telangiectasia (HHT). Successful results suggest it should be used as a first-line therapy.
Scientists in the United States have discovered that two existing FDA-approved drugs, clofarabine (Clolar™) and cladribine (Leustatin™), have a powerful inhibitory impact on Ewing sarcoma cells in the lab.
A team of scientist have developed a way to wirelessly deliver light into deep regions of the body to activate light-sensitive drugs for photodynamic therapy...
INTEGRA Biosciences is helping researchers to improve pipetting efficiency and ensure reliable results with a recently published guide to choosing the right micropipette...
The FDA has granted Fast Track designation to TAK-426, Takeda’s purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate...
Physicians have reported the first paediatric use of pyridostigmine to reverse complications from botulinum toxin therapy...
Patients could find that supplies of their medicines will be disrupted when the UK leaves the EU, according to a new briefing published by the Brexit Health Alliance...
The FDA has approved Lutathera for the treatment of a type of cancer that affects the pancreas the gastrointestinal tract...
Tecan’s range of advanced liquid handling solutions will soon be enhanced with the introduction of the new Fluent® Gx Automation Workstation*, designed specifically to meet the stringent needs of clinical and regulated laboratories...
The EMA has recommended granting a marketing authorisation in the EU for Lamzede a long-term enzyme replacement therapy for alpha-mannosidosis...
